Drugs / MK0954A
MK0954A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00480805 | Aug 2001 → Oct 2002 | hypertensive disorder, type 2 diabetes mellitus | Organon and Co | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK0954A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00480805 ↗ |
| Known as | HYZAAR | “MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks” NCT00480805 ↗ |
| Known as | losartan potassium (+) hydrochlorothiazide | “MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks” NCT00480805 ↗ |